Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery
Open Access
- 17 January 2024
- journal article
- research article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 7 (1) , e467
Abstract
Objective: This study evaluates the predictive value of copeptin for syndrome of inappropriate antidiuresis (SIAD) postpituitary transsphenoidal surgery (TSS).Design: Data from 133 consecutive patients undergoing TSS (November 2017–October 2022) at Oxford University Hospitals NHS trust are presented in this retrospective study.Methods: Logistic regression (LR) and receiver operating characteristic (ROC) curves were performed to evaluate the diagnostic utility of copeptin. The Mann–Whitney U test was used to compare copeptin levels between the SIAD and no SIAD groups.Results: Fourteen patients (10.8%) developed SIAD. Copeptin was available in 121, 53 and 87 patients for Days 1, 241 and 8 post‐TSS, respectively. LR for Day 1 copeptin to predict SIAD gave an odds ratio (OR) of 1.0 (95%CI 42 0.84–1.20, p = .99), area under‐ROC curve (AUC) was 0.49; Day 2 copeptin OR was 0.65 (95%CI 0.39–1.19, 43 p = .77), AUC was 0.57 LR for Day 1 sodium to predict SIAD gave an odds ratio (OR) of 1.0 (95%CI 0.85–1.21, p = .99), AUC was 0.50.Conclusions: In conclusion, our data provide no evidence for copeptin as a predictive marker for post‐TSS SIAD.Keywords
This publication has 11 references indexed in Scilit:
- Incidence and Factors Associated with Postoperative Delayed Hyponatremia after Transsphenoidal Pituitary Surgery: A Meta-Analysis and Systematic ReviewInternational Journal of Endocrinology, 2021
- A Copeptin-Based Approach in the Diagnosis of Diabetes InsipidusNew England Journal of Medicine, 2018
- A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgeryPituitary, 2017
- Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: ‘The Co-MED Study'Clinical Endocrinology, 2016
- Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria–polydipsia and hyponatremiaBest Practice & Research Clinical Endocrinology & Metabolism, 2016
- Postoperative Copeptin Concentration Predicts Diabetes Insipidus After Pituitary SurgeryThe Journal of Clinical Endocrinology & Metabolism, 2015
- Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary CenterJournal of Clinical Medicine, 2014
- Copeptin as a marker for arginine-vasopressin/antidiuretic hormone secretion in the diagnosis of paraneoplastic syndrome of inappropriate ADH secretionEndocrine, 2013
- Gender and renal function influence plasma levels of copeptin in healthy individualsClinical Science, 2009
- Pathophysiology of hyponatremia after transsphenoidal pituitary surgeryJournal of Neurosurgery, 1997